nach oben

Erschienen in:

01.07.2015 | Current Opinion

Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its Complications

verfasst von: Amarpreet S. Chawla, Chia-Wen Hsiao, Martha C. Romney, Ricardo Cohen, Francesco Rubino, Philip Schauer, Pierre Cremieux

Erschienen in: PharmacoEconomics | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Despite consistently supportive evidence of clinical effectiveness and economic advantages compared with currently available non-surgical obesity treatments, patient access to bariatric and metabolic surgery (BMS) is impeded. To address this gap and better understand the relationship between value and access, the objectives of this study were twofold: (i) identify the multidimensional barriers to adoption of BMS created by clinical guidelines, public policies, and health technology assessments; and, most importantly, (ii) develop recommendations for stakeholders to improve patient access to BMS. Updated public policies focused on treatment and clinical guidelines that reflect the demonstrated advantages of BMS, patient education on safety and effectiveness, updated reimbursement policies, and additional data on long-term BMS effectiveness are needed to improve patient access.

Glickman D, Parker L, Sim LJ, et al., editors. Accelerating progress in obesity prevention: solving the weight of the nation. Committee on Accelerating Progress in Obesity Prevention; Food and Nutrition Board; Institute of Medicine; Washington (DC): National Academies Press (US); 2012.

Wu Y, Lau BD, Bleich S, et al. Future research needs for childhood obesity prevention programs: identification of future research needs from comparative effectiveness review no. 115. Rockville (MD): Agency for Healthcare Research and Quality; 2013 (Future Research Needs Papers, No. 31.).

Foresight Report. Tackling obesities: future choices–project report. Government Office for Science, UK government. 2007. https://www.gov.uk/government/publications/reducing-obesity-future-choices. Accessed 4 Aug 2014.

Frühbeck G, Toplak H, Woodward E, et al. Obesity: the gateway to ill health—an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013;6:117–20.PubMed

Sassi F, Cecchini M, Lauer J, Chisholm D. Improving lifestyles, tackling obesity: the health and economic impact of prevention strategies. OECD Health Working Paper No. 48. OECD; 2009.

European Society for the Study of Obesity. Obesity. Policymaker survey 2013. A summary report. Available at: http://easo.org/wp-content/uploads/2013/09/C3_EASO_Survey_A4_LowRes.pdf. Accessed 4 Aug 2014.

Sassi, F, Hurst J. The prevention of lifestyle-related chronic diseases: an economic framework. OECD Health Working Paper, No. 32. OECD; 2008.

Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.PubMed

World Health Organization. Obesity and overweight. Fact sheet no. 311. Updated August 2014. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 4 Aug 2014.

10.

Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–14.PubMed

11.

Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff. 2009;28:822–31.

12.

Pendergast K, Wolf A, Sherrill B, et al. Impact of waist circumference difference on health-care cost among overweight and obese subjects: the PROCEED cohort. Value Health. 2010;13(4):402–10.PubMed

13.

Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.PubMedCentralPubMed

14.

Withrow D, Alter DA. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev. 2011;12(2):131–41.PubMed

15.

International Association for the Study of Obesity. Estimated relative risk of disease by BMI category: overweight and obesity. Available at: http://www.iaso.org/site_media/uploads/Appendix_Relative_Risk_Assessments_IASO.pdf. Accessed 4 Aug 2014.

16.

American Medical Association. AMA adopts new policies on second day of voting at annual meeting. Available at: http://www.ama-assn.org/ama/pub/news/news/2013/2013-06-18-new-ama-policies-annual-meeting.page. Accessed 4 Sept 2014.

17.

World Health Organization, Regional Office for Europe. Obesity. Available at: http://www.euro.who.int/en/health-topics/noncommunicable-diseases/obesity/obesity. Accessed 5 Aug 2014.

18.

Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31(1):219–30.PubMed

19.

United Health Foundation, the American Public Health Association and Partnership for Prevention. The future costs of obesity: national and state estimates of the impact of obesity on direct healthcare expenses. 2009. Available at: http://www.fightchronicdisease.org/sites/fightchronicdisease.org/files/docs/CostofObesityReport-FINAL.pdf. Accessed 4 Sept 2014.

20.

Erixon F, Brandt L, Krol M. Investing in obesity treatment to deliver significant healthcare savings: estimating the healthcare costs of obesity and the benefits of treatment. Brussels: European Center for International Political Economy occasional paper 01/2014; 2014.

21.

Trogdon JG, Finkelstein EA, Hylands T, Dellea PS, Kamal-Bahl SJ. Indirect costs of obesity: a review of the current literature. Obes Rev. 2008;9(5):489–500.PubMed

22.

Direct healthcare cost of obesity in Brazil. An application of the cost-of-illness method from the perspective of the public health system in 2011. PLoS One. 2015;10(4):e0121160.

23.

International Diabetes Federation. IDF diabetes atlas. 6th ed. 2014 update. Available at: http://www.idf.org/diabetesatlas/update-2014. Accessed 14 Apr 2015.

24.

Bockelbrink A, Stöber E, Roll S, et al. Evaluation of medical and health economic effectiveness of bariatric surgery (obesity surgery) versus conservative strategies in adult patients with morbid obesity. GMS Health Technol. Assess. 2008;4:1–10

25.

National Health Service, Quality Improvement Scotland. Bariatric surgery in adults. Evidence Note. Number 28. 2010. http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/earlier_evidence_notes/evidence_note_28.aspx. Accessed 5 Aug 14.

26.

National Health Service, Quality Improvement Scotland. What is the relative clinical effectiveness, cost effectiveness and safety of different bariatric surgery techniques (gastric bypass, gastric banding and sleeve gastrectomy)? Technologies Scoping Report. 2012;6:1–7.

27.

Pichon RA, Augustovski F, Ferrante D, et al. Usefulness of surgical treatments for obesity. Ciudad de Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS); 2004.

28.

Canadian Agency for Drugs and Technologies in Health. Bariatric surgery for obese patients with co-morbidities: a review of clinical effectiveness, cost-effectiveness, and guidelines. Rapid response report: summary with critical appraisal. 2013. https://www.cadth.ca/sites/default/files/pdf/htis/aug-2013/RC0468%20Bariatric%20Surgery%20Final.pdf. Accessed 19 Oct 2014.

29.

Klarenbach S, Padwal R, Wiebe N, et al. Bariatric surgery for severe obesity: systematic review and economic evaluation. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010 (Technology report no. 129).

30.

Medical Advisory Secretariat. Bariatric surgery: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(1):1–148.

31.

Medical Advisory Secretariat (2009c). Application of the Ontario Diabetes Economic Model (ODEM) to determine the cost-effectiveness and budget impact of selected type 2 diabetes interventions in Ontario. Ont Health Technol Assess Ser. 2009;9(25):1–21.

32.

Rubino F, Shukla A, Pomp A, et al. Bariatric, metabolic, and diabetes surgery: what’s in a name? Ann Surg. 2014;259(1):117–22.PubMed

33.

Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.PubMedCentralPubMed

34.

Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.PubMed

35.

Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.PubMedCentralPubMed

36.

Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.PubMed

37.

Cremieux PY, Eapen S, Trask SW, Ghosh A. Weighing the clinical benefits and economic impact of bariatric surgery in morbidly obese patients with diabetes. Can J Diabetes. 2011;35:89–98.

38.

Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.PubMed

39.

Shah SS, Todkar JS, Shah PS, Cummings DE. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis. 2010;6(4):332–8.PubMedCentralPubMed

40.

Bariatric surgery for diabetes deemed Cleveland Clinic’s top medical innovation for 2013. Available at: http://medcitynews.com/2012/10/cleveland-clinic-deems-bariatric-surgery-for-diabetes-the-top-medical-innovation-for-2013/. Accessed 4 Sept 2014.

41.

Institute for Health Metrics and Evaluation (IHME). Overweight and obesity viz. Seattle (WA): IHME, University of Washington; 2014. Available from http://vizhub.healthdata.org/obesity. Accessed 19 Oct 2014.

42.

Dixon JB. Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA. 2008;299(3):316–23.PubMed

43.

Bariatric surgery: why only a last resort? Lancet Diabetes Endocrinol. 2014;2(2):91.

44.

Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract. 2013;19(2):337–72.PubMedCentralPubMed

45.

Allison DB, Downey M, Atkinson RL, et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring). 2008;16(6):1161–77.PubMed

46.

Salem L, Jensen Flum CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg. 2005;200(2):270–8.PubMed

47.

Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br J Surg. 2011;98(10):1422–9.PubMed

48.

Faria GR, Preto JR, Costa-Maia J. Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model. Obes Surg. 2013;23(4):460–6.PubMed

49.

Hashemi L, Minshall ME. Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patients in Canada. Value Health. 2010;13(3):A59.

50.

Neovius M. Health economics of obesity from a European perspective. Presentation at 18th European Congress on Obesity ECO 2011 Istanbul, Turkey. Obes Rev. 2011;12(Suppl 1):22.

51.

Ghiassi S, Morton J, Bellatorre N, Eisenberg D. Short-term medication cost savings for treating hypertension and diabetes after gastric bypass. Surg Obes Relat Dis. 2012;8(3):269–74.PubMed

52.

Mason RJ, Moroney JR, Berne TV. The cost of obesity for nonbariatric inpatient operative procedures in the United States: national cost estimates obese versus nonobese patients. Ann Surg. 2013;258(4):541–53.PubMed

53.

Tice JA. Bariatric surgery for the treatment of type 2 diabetes mellitus. California Technology Assessment Forum; 2012.

54.

Segal JB, Clark JM, Shore AD. Prompt reduction in use of medications for comorbid conditions after bariatric surgery. Obes Surg. 2009;19(12):1646–56.PubMed

55.

Neovius M, Narbro K, Keating C, et al. Health care use during 20 years following bariatric surgery. JAMA. 2012;308(11):1132–41.PubMed

56.

Terranova L, Busetto L, Vestri A, Zappa MA. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012;22(4):646–53.PubMed

57.

Picot J, Jones J, Colquitt JL, et al. Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation. Obes Surg. 2012;22(9):1496–506.PubMed

58.

Pollock RF, Muduma G, Valentine WJ. Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK. Diabetes Obes Metab. 2013;15(2):121–9.PubMed

59.

Nasciben V, Saggia MG. A cost-effectiveness analysis of conventional treatment versus bariatric surgery for obese patients with type-2 diabetes and hypertension as comorbidities. Preliminary results under the Brazilian private payer perspective. Value Health. 2010;13 (3):A209.

60.

Song HJ, Kwon JW, Kim YJ, et al. Bariatric surgery for the treatment of severely obese patients in South Korea: is it cost effective? Obes Surg. 2013;23(12):2058–67.PubMed

61.

Song HJ, Lee HJ, Lee JY, et al. Clinical and cost effectiveness of bariatric surgery for obese patients: economic evaluation in South Korea. Value Health. 2012;15(4):A78.

62.

Cahill AG, Odibo A, Jungheim E, et al. Pre-pregnancy gastric bypass for the morbidly obese: a decision and economic analysis. Am J Obstet Gynecol. 2012;206(1 Suppl. 1):S274.

63.

Campbell J, McGarry LJ, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity. Am J Manag Care. 2010;16(7):e174–87.PubMed

64.

Chang S-H, Stoll CRT, Colditz GA. Cost-effectiveness of bariatric surgery: should it be universally available? Maturitas. 2011;69(3):230–8.PubMed

65.

Hoerger TJ, Zhang P, Segel JE, et al. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.PubMedCentralPubMed

66.

Borg S, Näslund I, Persson U, Odegaard K. Budget impact analysis of surgical treatment for obesity in Sweden. Scand J Surg. 2012;101(3):190–7.PubMed

67.

Johnston RAD, Caines K, Mulvey-Goldsmith R, et al. Financial impact of laparoscopic Roux-en-Y gastric bypass surgery on direct costs of diabetes-related medication in a UK population. Diabet Med. 2011;28:167–8.

68.

Zanela OO, Cabra HA, Anaya P, et al. Use of a discrete event simulation model to estimate long term economic outcomes of bariatric surgery in morbidly-obese type-2 diabetic patients in Mexico. Value Health. 2011;14(7):A568.

69.

Finkelstein EA, Allaire BT, Globe D, Dixon JB. The business case for bariatric surgery revisited: a non-randomized case-control study. PLoS One. 2013;8(9):e75498.PubMedCentralPubMed

70.

Klein S, Ghosh A, Cremieux PY, et al. Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m2. Obesity (Silver Spring). 2011;19(3):581–7.PubMedCentralPubMed

71.

Mullen DM, Marr TJ. Longitudinal cost experience for gastric bypass patients. Surg Obes Relat Dis. 2010;6(3):243–8.PubMed

72.

Sheppard CE, Lester ELW, Chuck AW, et al. The economic impact of weight regain. Gastroenterol Res Pract. 2013;2013:379564.PubMedCentralPubMed

73.

Australian Government, Department of Health, Medical Services Advisory Committee. Review of items for the surgical treatment of obesity. Canberra (ACT): Medical Services Advisory Committee; 2011.

74.

Stephenson M, Hogan S. The safety, effectiveness and cost effectiveness of surgical and non-surgical interventions for patients with morbid obesity. New Zealand Health Technology Assessment Brief. 2007. Available at: www.otago.ac.nz/christchurch/otago014009.pdf. Accessed 19 Oct 2014.

75.

Bariatric surgery for the treatment of morbid obesity. Brazilian Health Technol Assess Bull. 2008;3(5):1–11.

76.

Kelles SM, Barreto SM, Guerra HL. Costs and usage of healthcare services before and after open bariatric surgery. Sao Paulo Med J. 2011;129(5):291–9.PubMed

77.

Canadian Agency for Drugs and Technologies in Health (CADTH). Bariatric surgery for the treatment of morbid obesity: guidelines. 2008. Available at: http://www.cadth.ca/media/pdf/htis/Bariatric%20Surgery%20for%20Patients%20with%20Morbid%20Obesity%20Guidelines.pdf. Accessed 1 Oct 2014.

78.

Martin AR, Klemensberg J, Klein LV, et al. Comparison of public and private bariatric surgery services in Canada. Can J Surg. 2011;54(3):154–69.PubMedCentralPubMed

79.

Starfield B. Reinventing primary care: lessons from Canada for the United States. Health Aff. 2010;29(5):1030–6.

80.

Canadian Institute for Health Information. Bariatric surgery in Canada. May 2014. Available at: https://secure.cihi.ca/free_products/Bariatric_Surgery_in_Canada_EN.pdf. Accessed 19 Oct 2014.

81.

Lazzati A, Guy-Lachuer R, Delaunay V, et al. Bariatric surgery trends in France: 2005–2011. Surg Obes Relat Dis. 2014;10(2):328–34.PubMed

82.

Haute Autorite De Sante (HAS). Obesity surgery in adults: information for the general practitioner. 2009. Available at: http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/obesity_surgery_-_guidelines.pdf. Accessed 19 Oct 2014.

83.

Institute for Quality and Efficiency in Health Care (IQWIG). Treatment of obesity in patients with type 2 diabetes mellitus: guideline synopsis and supplementary search for and assessment of systematic reviews. IQWiG Reports—Commission No. V09-02. Institute for Quallity and Efficiency in Health Care; 2012.

84.

Runkel N, Colombo-Benkmann M, Hüttl TP. Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis. 2011;26:397–404.PubMed

85.

Working Group of the Guideline for the Prevention and Treatment of Childhood and Juvenile Obesity. Clinical practice guideline for the prevention and treatment of childhood and juvenile obesity. Quality plan for the Spanish National Healthcare System of the Spanish Ministry for Health and Social Policy; Catalan Agency for Health Technology Assessment, 2009. Clinical practice guideline: CAHTA no. 2007/25.

86.

Lee WJ. Consensus of Asian Diabetic Surgery Summit (ADSS) and APBSS. 2005. Available at: http://plaza.umin.ne.jp/jsto/information/ifso_apc/jp/program_overview/shoroku/ifso_c.pdf. Accessed 4 Aug 2014.

87.

Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.PubMed

88.

Healthy Lives. Healthy people. A call to action for England. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213720/dh_130487.pdf. Accessed 19 Oct 2014.

89.

Centers for Medicare and Medicaid Services. Proposed decision memo for bariatric surgery for the treatment of morbid obesity – facility certification requirement (CAG-00250R3). 2013. Available at: http://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=266&NcaName=Bariatric+Surgery+for+the+Treatment+of+Morbid+Obesity+-+Facility+Certification+Requirement&TimeFrame=7&DocType=All&bc=AQAAIAAACAAAAA%3D%3D&. Accessed 5 Aug 2014.

90.

Lee JS, Sheer JLO, Lopez N, Rosenbaum S. Coverage of obesity treatment: a state-by-state analysis of Medicaid and state insurance laws. Public Health Rep. 2010;125(4):596–604.PubMedCentralPubMed

91.

Flum DR, Kwon S, MacLeod K, et al. The use safety and cost of bariatric surgery before and after Medicare’s national coverage decision. Ann Surg. 2011;254(6):860–5.PubMedCentralPubMed

92.

CIGNA. Healthcare coverage position: bariatric surgery. 2006. Available at: https://my.cigna.com/teamsite/health/provider/medical/procedural/coverage_positions/medical/mm_0051_coveragepositioncriteria_bariatric_surgery.pdf. Accessed 5 Aug 2014.

93.

Lund TB, Sandoe P, Lassen J. Attitudes to publicly funded obesity treatment and prevention. Obesity (Silver Spring). 2011;19(8):1580–5.

94.

Brochu PM, Esses VM. Weight prejudice and medical policy: support for an ambiguously discriminatory policy is influenced by prejudice-colored glasses. Anal Soc Issues Public Policy. 2009;9:117–33.

95.

Sikorski C, Luppa M, Kaiser M, et al. The stigma of obesity in the general public and its implications for public health: a systematic review. BMC Public Health. 2011;11:661.PubMedCentralPubMed

96.

Puhl RM, Heuer CA. The stigma of obesity: a review and update. Obesity (Silver Spring). 2009;17:941–64.PubMed

97.

Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803–9.PubMed

98.

Germani G, Lazzaro S, Gnoato F, et al. Nonadherent behaviors after solid organ transplantation. Transplant Proc. 2011;43:318–23.PubMed

99.

Flodgren G, Deane K, Dickinson HO. Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in overweight and obese people. Cochrane Database Syst Rev. 2010;(3):CD000984.

100.

Martin M, Beekley A, Kjorstad R, Sebesta J. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6(1):8–15.PubMed

101.

Chawla AS, Tao C, Faulkner EC, et al. Role of patients in sharing the decision to undertake bariatric surgery for treatment of obesity: a global market perspective. PDB118. In: ISPOR 19th Annual International Meeting, 31 May–4 June 2014; Montreal.

102.

Yoong SL, Carey ML, Sanson-Fisher RW, D’Este CA. A cross-sectional study assessing Australian general practice patients’ intention, reasons and preferences for assistance with losing weight. BMC Fam Pract. 2013;14:187.PubMedCentralPubMed

103.

Nadalini L, Zenti MG, Masotto L, et al. Improved quality of life after bariatric surgery in morbidly obese patients. Interdisciplinary Group of Bariatric Surgery of Verona (G.I.C.O.V.). G Chir. 2014;35(7–8):161–4.PubMedCentralPubMed

104.

Henretta MS, Copeland AR, Kelley SL, et al. Perceptions of obesity and cancer risk in female bariatric surgery candidates: highlighting the need for physician action for unsuspectingly obese and high risk patients. Gynecol Oncol. 2014;133(1):73–7.PubMed

105.

Lebrun LA, Chowdhury J, Sripipatana A, et al. Overweight/obesity and weight-related treatment among patients in U.S. federally supported health centers. Obes Res Clin Pract. 2013;7(5):e377–90.PubMed

106.

Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;3:1909–17.

107.

Wallace AE, Young-Xu Y, Hartley D, Weeks WB. Racial, socioeconomic, and rural–urban disparities in obesity-related bariatric surgery. Obes Surg. 2010;3:1354–60.

108.

Korda RJ, Joshy G, Jorm LR, et al. Inequalities in bariatric surgery in Australia: findings from 49,364 obese participants in a prospective cohort study. Med J Aust. 2012;197(11):631–6.PubMed

109.

Padwal RS, Chang HJ, Klarenbach S, Sharma AM, Majumdar SR. Characteristics of the population eligible for and receiving publicly funded bariatric surgery in Canada. Int J Equity Health. 2012;3:54.

110.

National Heart Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report. Bethesda (MD): National Heart, Lung, and Blood Institute; 1998.

111.

American Gastroenterological Association. Medical position statement on obesity. Gastroenterology. 2002;3:879–81.

112.

The Society for Surgery of the Alimentary Tract (SSAT). SSAT patient care guidelines: surgery for obesity. 2005. Available at: http://www.ssat.com/cgi-bin/guidelines_SurgeryObesity_EN.cgi. Accessed 19 Oct 2014.

113.

Snow V, Barry P, Fitterman N, et al. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142:525–31.PubMed

114.

National Institute for Health and Care Excellence. Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. 2006. Available at: http://www.nice.org.uk/guidance/cg43/chapter/guidance. Accessed 19 Oct 2014.

115.

Society for American Gastrointestinal and Endoscopic Surgeons. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Endosc. 2008;22(10):2281–300.

116.

Scottish Intercollegiate Guidelines Network. Management of obesity. A national clinical guideline. 2010. Available at: http://www.sign.ac.uk/pdf/sign115.pdf. Accessed 19 Oct 2014.

117.

International Diabetes Federation (IDF). Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628–42.PubMedCentral

118.

Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg. 2012;22(5):677–84.PubMed

119.

Department of Veterans Affairs/Department of Defense. VA/DoD clinical practice guideline for screening and management of overweight and obesity. 2014. Available at: http://www.healthquality.va.gov/guidelines/CD/obesity/VADoDCPGManagementOfOverweightAndObesityFINAL070714.pdf. Accessed 19 Oct 2014.

120.

Obesity: identification, assessment and management of overweight and obesity in children, young people and adults. National Institute for Health and Care Excellence (NICE) draft guideline for consultation. 11 July 2014. NICE; 2014.

121.

Department of Veterans Affairs/Department of Defense. VA/DoD clinical practice guideline for screening and management of overweight and obesity. 2006. http://www.healthquality.va.gov/guidelines/CD/obesity/VADoDCPGManagementOfOverweightAndObesityFinal.pdf. Accessed 19 Oct 2014.

122.

Fischer S, Zechmeister-Koss I, Huic M. Duodeno-jejunal bypass liner (DJBL) for patients with obesity, with/without type 2 diabetes mellitus. Decision Support Document 67. Ludwig Boltzmann Institute for Health Technology Assessment; 2013.

123.

Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;(8):CD003641.

124.

Ontario Health Technology Advisory Committee (OHTAC). OHTAC recommendation: laparoscopic adjustable gastric banding. Canadian Agency for Drugs and Technologies in Health; 2010.

125.

Laparoscopic adjustable gastric banding in patients with body mass index less than 35 kg/m² with weight-related comorbidity. Technol. Eval. Cent. Assess. Program Exec. Summ. 2012;27(3):1–5.

126.

Bariatric surgery in patients with diabetes and body mass index less than 35 kg/m². Technol. Eval. Cent. Assess. Program Exec. Summ. 2012;27(2):1–3.

127.

Habermann EB, Durham SB, Dorman R, et al. Trends in bariatric surgery in Medicare beneficiaries. Data Points # 17. Rockville (MD): Agency for Healthcare Research and Quality; Nov 2012. AHRQ Publication No. 12-EHC104-EF.

128.

Tice JA. Laparoscopic adjustable silicone gastric banding for obesity. California Technology Assessment Forum; 2009.

129.

Walsh J. Sleeve gastrectomy as a stand-alone bariatric procedure for obesity. California Technology Assessment Forum; 2010.

130.

Maglione MA, Gibbons MM, Livhits M, et al. Bariatric surgery and nonsurgical therapy in adults with metabolic conditions and a body mass index of 30.0 to 34.9 kg/m². Comparative Effectiveness Reviews No. 82. Rockville (MD): Agency for Healthcare Research and Quality (US); Jun 2013. Report No.: 12(13)-EHC139-EF.

131.

National Institutes for Health. Managing overweight and obesity in adults. Systematic evidence review from the Obesity Expert Panel, 2013. National Institutes of Health; 2013.

132.

Daniel S, Soleymani T, Garvey WT. A complication-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):377–88.PubMedCentralPubMed

133.

Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obesity. 2009;33:289–95.

134.

Cohen RV, Rubino F, Schiavon C, Cummings DE. Diabetes remission without weight loss after duodenal bypass surgery. Surg Obes Relat Dis. 2012;8(5):e66–8.PubMedCentralPubMed

135.

Pham S, Gancel A, Scotte M, et al. Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: a retrospective study. J Obes. 2014;2014:638203.PubMedCentralPubMed

136.

Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7):716–26.PubMed

137.

Ren Y, Yang W, Yang J, Wang C. Effect of Roux-en-Y gastric bypass with different pouch size in Chinese T2DM patients with BMI 30–35 kg/m². Obes Surg. 2015;25(3):457–63.PubMed

138.

Cohen R, Caravatto PP, Petry T. Metabolic surgery for type 2 diabetes in patients with a BMI of <35 kg/m(2): a surgeon’s perspective. Obes Surg. 2013;23(6):809–18.PubMed

139.

Ngiam KY, Lee WJ, Lee YC, Cheng A. Efficacy of metabolic surgery on HbA1c decrease in type 2 diabetes mellitus patients with BMI <35 kg/m²: a review. Obes Surg. 2014;24(1):148–58.PubMed

140.

Noun R, Chakhtoura G, Nasr M, et al. Laparoscopic sleeve gastrectomy for mildly obese patients (body mass index of 30 <35 kg/m²): operative outcome and short-term results. J Obes. 2012;2012:813650.PubMedCentralPubMed

141.

Abbatini F, Capoccia D, Casella G, et al. Type 2 diabetes in obese patients with body mass index of 30–35 kg/m²: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis. 2012;8(1):20–4.PubMed

142.

Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):138–41.PubMed

143.

Ionut V, Bergman RN. Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol. 2011;5(5):1263–82.PubMedCentralPubMed

144.

American Diabetes Association. Standards of medical care in diabetes–2015. Diabetes Care. 2015;38(Suppl 1):S1–94.

145.

Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.PubMed

146.

Powell MS, Fernandez AZ Jr. Surgical treatment for morbid obesity: the laparoscopic Roux-en-Y gastric bypass. Surg Clin N Am. 2011;91(6):1203–24.PubMed

147.

Ravesloot MJ, Hilgevoord AA, van Wagensveld BA, de Vries N. Assessment of the effect of bariatric surgery on obstructive sleep apnea at two postoperative intervals. Obes Surg. 2014;24(1):22–31.PubMed

148.

Christou NV. Access to bariatric (metabolic) surgery in Canada. Can J Diabetes. 2011;35:123–8.

149.

Vidal P, Ramón JM, Goday A, et al. Lack of adherence to follow-up visits after bariatric surgery: reasons and outcome. Obes Surg. 2014;24(2):179–83.PubMed

150.

Arterburn D, Bogart A, Coleman KJ, et al. Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013;7(4):e258–68.PubMed

151.

Huang C, Shabbir A, Lo CH, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type ii diabetes mellitus in Chinese patients with body mass index of 25–35. Obes Surg. 2011;21:1344–9.PubMedCentralPubMed

152.

Li Q, Chen L, Yang Z, Ye Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index <35 kg/m2. Diabetes Obes Metab. 2012;14(3):262–70.PubMed

153.

United Health Care. Medical policy: bariatric surgery. 2014. Available at: https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Bariatric_Surgery.pdf. Accessed 5 Aug 2014.

Titel: Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its Complications
verfasst von: Amarpreet S. Chawla
Chia-Wen Hsiao
Martha C. Romney
Ricardo Cohen
Francesco Rubino
Philip Schauer
Pierre Cremieux
Publikationsdatum: 01.07.2015
Verlag: Springer International Publishing
Erschienen in: PharmacoEconomics / Ausgabe 7/2015
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI: https://doi.org/10.1007/s40273-015-0302-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its Complications

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2015

Do Statins Reduce the Health and Health Care Costs of Obesity?

Cost-Effectiveness Analysis of Qsymia for Weight Loss

For a Step Change to Curb the Obesity Epidemic

Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status

Obesity in the Context of Aging: Quality of Life Considerations

The Effect of Obesity and Chronic Conditions on Medicare Spending, 1987–2011